Results 111 to 120 of about 19,052 (152)

Age-Dependent Toxicity Patterns in Medulloblastoma: A Comparative Analysis of Treatment-Related Adverse Events Between Pediatric and Adult Populations. [PDF]

J Clin Med
Ruggiero A, Talloa D, Romano A, Maurizi P, Mastrangelo S, Verdolotti T, Mariani S, Chiesa S, di Bonaventura R, Massimi L, Tamburrini G, Albanese A, Attinà G.   +12 more
europepmc   +1 more source

Exploring and Overcoming Challenges for Efficient Audiological Testing in Children Under 5 Years of Age-Screening with Otoacoustic Emissions. [PDF]

Audiol Res
Streefkerk N, Diepstraten FA, Veld EAHI', Am Zehnhoff-Dinnesen A, Grotel MV, Neumann K, Meijer AJM, Amant F, Parfitt R, Verešpejová L, Brock PR, Hunter LL, Helleman HW, Brooks B, Rajput KM, Knight K, van den Heuvel-Eibrink MM, Hoetink AE.   +17 more
europepmc   +1 more source

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study. [PDF]

EClinicalMedicine
Sanchez VA, Dinh PC, Monahan PO, Fung C, Althouse S, Stump T, Rooker J, Dolan ME, Feldman DR, Hamilton RJ, Pierorazio PM, Martin NE, Huddart R, Kollmannsberger C, Root J, Sesso HD, Weinzierl M, Einhorn LH, Frisina RD, Travis LB.   +19 more
europepmc   +1 more source

Activating GPR55 protects cochlear hair cells against cisplatin-induced ototoxicity via inhibiting MAPK pathway. [PDF]

Sci Rep
Guo L, Wang R, Wang Y, Ruan H, Zhang Y, Wei Y, Du J, Fang Q, Yang J, Cao W.   +9 more
europepmc   +1 more source

Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (NHS) Cancer Ambulatory Care Setting. [PDF]

Otol Neurotol
Mehta N, Awad A, Forbes M, Iliadou E, Katiri R, Ferdous T, Lowe H, Ensell L, Alifrangis C, Schilder AGM, Windsor R.   +10 more
europepmc   +1 more source

Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey. [PDF]

Cancer Med
Lacey C, Clark K, Debacker JR, Stuehm H, Hungerford M, Milnes T, Johansson K, Mannino R, Graff JN, Konrad-Martin D.   +9 more
europepmc   +1 more source

A viscosity-tunable microgel-in-sol phase for localized inner ear delivery of small hydrophilic drug. [PDF]

Mater Today Bio
Kim S, Kang JH, Won SS, Yang KJ, Kim S, Kim DK, Shin M.   +6 more
europepmc   +1 more source

Correction: Histone deacetylase inhibitors are protective in acute but not in chronic models of ototoxicity. [PDF]

Front Cell Neurosci
Yang CH, Liu Z, Dong D, Schacht J, Arya D, Sha SH.   +5 more
europepmc   +1 more source

Rediscovering the Gut-Mito-Ear Axis: A Systems-Biology Framework for Ototoxic Vulnerability and Microbiome-Targeted Prevention. [PDF]

Cells
Yim CD, Kwon H, Park JJ, Lee SJ, Seo JH, Hah YS, Ahn SK.   +6 more
europepmc   +1 more source

AMPKα Silencing Prevents Kanamycin-Induced Ototoxicity in an Acute Mouse Model. [PDF]

Sens Neurosci
Zou S, Wu F, Fang Q, He Z, Su H, Xu S, Sha SH.   +6 more
europepmc   +1 more source